Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ben Glickman Shares of CervoMed nearly doubled Thursday after beginning trading under a new ticker following a merger. The stock was up 98% to $13.10 in...
/PRNewswire/ -- CervoMed Inc. (formerly known as Diffusion Pharmaceuticals Inc.) (NASDAQ: CRVO), now a clinical-stage company focused on developing treatments...
/PRNewswire/ -- EIP Pharma Inc. ("EIP Pharma" or the "Company"), a privately held clinical-stage company focused on developing treatments for neurodegenerative...
/PRNewswire/ -- EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases, today announced that the Company's...
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference BOSTON, MA - August 3, 2023 - EIP Pharma Inc., a clinical stage company focused on developing treatments...